Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approvals
Pharma
Roche-Hanmi, Akeso, a congressman's concerns—Fierce Pharma Asia
Roche signed an obesity deal with Hanmi. Akeso CEO defends ivonescimab's NSCLC data. A U.S. congressman says China is "beating us on our ground game."
Angus Liu
Aug 28, 2026 9:00am
Priovant secures 1st FDA nod in rare skin and muscle disease
Aug 27, 2026 9:30pm
Regulatory tracker: GSK, ViiV Healthcare
Aug 26, 2026 2:40pm
FDA approves Otsuka’s first-in-class ADHD drug Simtriyo
Jul 27, 2026 12:42pm
Nuvalent deal delivers GSK’s first-ever lung cancer approval
Jul 22, 2026 3:15pm
Fierce Biotech
FDA halts release of new drug rejection letters
Jul 8, 2026 1:33pm